ETtechICICI Direct has buy call on Healthcare Global Enterprises with a target price of Rs 370.The current market price of Healthcare Global Enterprises is Rs 286.3.
Healthcare Global Enterprises, incorporated in the year 1998, is a Small Cap company (having a market cap of Rs 3991.62 Crore) operating in Hospitals & Allied Services sector.
Healthcare Global Enterprises key Products/Revenue Segments include Pharmaceuticals, Income from Medical and Healthcare Services, Other Operating Revenue and Grants for the year ending 31-Mar-2022.
Financials
For the quarter ended 30-09-2022, the company has reported a Consolidated Total Income of Rs 421.97 Crore, up 2.68 % from last quarter Total Income of Rs 410.96 Crore and up 18.78 % from last year same quarter Total Income of Rs 355.26 Crore. Company has reported net profit after tax of Rs 5.29 Crore in latest quarter.
The company’s top management includes Dr.B S Ajai Kumar, Mr.Jeyandran Venugopal, Mr.Meghraj Arvindrao Gore, Mr.Amit Soni, Mr.Siddharth Patel, Mr.Rajagopalan Raghavan, Ms.Geeta Mathur, Mr.Abhay Prabhakar Havaldar, Mr.Shanker Annaswamy, Ms.Anjali Ajaikumar Rossi, Mr.Pradip Kanakia. Company has B S R & Co. LLP as its auditors. As on 30-09-2022, the company has a total of 14 Crore shares outstanding.
Investment Rationale
EBITDA during the quarter is expected at Rs 82 crore, up 9.4% QoQ. EBITDA margins are likely to improve 113 bps QoQto 18.9%. HCG is expected to post a net profit of Rs 20 crore.
Promoter/FII Holdings
Promoters held 71.39 per cent stake in the company as of 30-Sep-2022, while FIIs owned 7.73 per cent, DIIs 4.02 per cent.
Healthcare Global Enterprises, incorporated in the year 1998, is a Small Cap company (having a market cap of Rs 3991.62 Crore) operating in Hospitals & Allied Services sector.
Healthcare Global Enterprises key Products/Revenue Segments include Pharmaceuticals, Income from Medical and Healthcare Services, Other Operating Revenue and Grants for the year ending 31-Mar-2022.
Financials
For the quarter ended 30-09-2022, the company has reported a Consolidated Total Income of Rs 421.97 Crore, up 2.68 % from last quarter Total Income of Rs 410.96 Crore and up 18.78 % from last year same quarter Total Income of Rs 355.26 Crore. Company has reported net profit after tax of Rs 5.29 Crore in latest quarter.
The company’s top management includes Dr.B S Ajai Kumar, Mr.Jeyandran Venugopal, Mr.Meghraj Arvindrao Gore, Mr.Amit Soni, Mr.Siddharth Patel, Mr.Rajagopalan Raghavan, Ms.Geeta Mathur, Mr.Abhay Prabhakar Havaldar, Mr.Shanker Annaswamy, Ms.Anjali Ajaikumar Rossi, Mr.Pradip Kanakia. Company has B S R & Co. LLP as its auditors. As on 30-09-2022, the company has a total of 14 Crore shares outstanding.
Investment Rationale
EBITDA during the quarter is expected at Rs 82 crore, up 9.4% QoQ. EBITDA margins are likely to improve 113 bps QoQto 18.9%. HCG is expected to post a net profit of Rs 20 crore.
Promoter/FII Holdings
Promoters held 71.39 per cent stake in the company as of 30-Sep-2022, while FIIs owned 7.73 per cent, DIIs 4.02 per cent.
(Disclaimer: Recommendations given in this section or any reports attached herein are authored by an external party. Views expressed are that of the respective authors/entities. These do not represent the views of Economic Times (ET). ET does not guarantee, vouch for, endorse any of its contents and hereby disclaims all warranties, express or implied, relating to the same. Please consult your financial adviser and seek independent advice.
Read More News on
(What's moving Sensex and Nifty Track latest market news, stock tips and expert advice on ETMarkets. Also, ETMarkets.com is now on Telegram. For fastest news alerts on financial markets, investment strategies and stocks alerts, subscribe to our Telegram feeds.)
...moreDownload The Economic Times News App to get Daily Market Updates & Live Business News.